Related Experiment Videos
Acute otitis media in children: are decongestants or antihistamines necessary?
Abstract:
This study was designed to investigate the efficacy of a decongestant-antihistamine preparation in combination with antibiotic treatment of acute otitis media. The effectiveness of a new Dimetapp (DIM) preparation was assessed in comparison with each of its components (brompheniramine maleate [BPM] and phenylephrine hydrochloride [PEH] as well as a placebo (PL) vehicle in the treatment of acute otitis media. In a randomized double blind study, 98 children were treated in the emergency department or outpatient medical clinics at Children's Hospital of Michigan with amoxicillin and either DIM, BPM, PEH, or PL. They were evaluated at two weeks by clinical examination, pneumatoscopy, and tympanometry. Fifty-eight patients (59%) continued to have evidence of fluid in the middle ear. These patients were continued on the test medications for another two weeks and then reevaluated. There were significant differences between the treatment groups (DIM, BPM, and PEH) and the control PL group; the patients receiving Dimetapp or placebo fared better than those receiving BPM or PEH. However, there was no difference in the overall response between Dimetapp and placebo. Antihistamine-decongestant therapy does not appear to be necessary in the treatment of acute otitis media in children.
Insights
This study found that antihistamine-decongestant preparations like Dimetapp do not improve treatment outcomes for acute otitis media in children when combined with antibiotics. Antibiotic therapy alone is sufficient for treating this common childhood ear infection.
Area of Science:
- Pediatrics
- Otolaryngology
- Pharmacology
Background:
- Acute otitis media (AOM) is a common childhood illness often treated with antibiotics.
- The role of adjunctive antihistamine-decongestant therapy in AOM management remains debated.
- This study evaluated a specific combination preparation alongside its individual components.
Purpose of the Study:
- To assess the efficacy of a Dimetapp preparation (DIM) compared to its components (brompheniramine maleate [BPM] and phenylephrine hydrochloride [PEH]) and placebo (PL) as an adjunct to antibiotic treatment for AOM.
- To determine if antihistamine-decongestant therapy offers additional benefits beyond standard antibiotic care in pediatric AOM.
Main Methods:
- A randomized, double-blind study involving 98 children treated with amoxicillin and either DIM, BPM, PEH, or PL.
- Children were evaluated at two weeks using clinical examination, pneumatoscopy, and tympanometry.
- Patients with persistent middle ear effusion were continued on medication for an additional two weeks.
Main Results:
- No significant difference in overall treatment response was observed between the Dimetapp (DIM) group and the placebo (PL) group.
- Patients receiving DIM or PL showed better outcomes than those treated with brompheniramine maleate (BPM) or phenylephrine hydrochloride (PEH) alone.
- A substantial proportion of children (59%) had persistent middle ear fluid at the initial two-week evaluation.
Conclusions:
- Antihistamine-decongestant therapy, including combination preparations like Dimetapp, does not appear to be necessary or beneficial for treating acute otitis media in children when used with antibiotics.
- Standard antibiotic treatment is likely sufficient for managing pediatric AOM.
- Further research may explore specific patient subgroups or alternative treatment strategies if needed.